Home> Products> valpotreat cr 500 therapy

{ "products": [ { "_id": "666c1007162db0236048bac5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 500 ", "description": "VALPOTREAT CR 500 \nSodium Valproate CR 500 mg\nIntroduction:\n\nVALPOTREAT CR 500 contains Sodium Valproate, a potent anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 500mg, VALPOTREAT CR 500 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 500 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 500 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 500 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 500 for adults typically starts at 500mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 500mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 500 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 500 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/valpotreat-cr-500-134217", "price": 121.18, "discountamount": 36.35, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "food", "time", "need", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "epilepsy", "severity", "patients", "Benefits", "frequency", "two doses", "adherence", "medication", "mood swings", "information", "initial dose", "GABA) levels", "tolerability", "sterispharma", "Key Features", "Introduction", "sterisonline", "various types", "CALL/WHATSAPP", "liver function", "Initial Dosage", "patient safety", "overall health", "manic episodes", "steady release", "mood stability", "mood stabilizer", "symptom control", "frequent dosing", "dosage strength", "seizure episodes", "absence seizures", "bipolar disorder", "treatment regimen", "clinical response", "neuronal activity", "Mood Stabilization", "Regular monitoring", "Sodium Valproate CR", "Continued Monitoring", "long-term management", "therapeutic efficacy", "Anticonvulsant Action", "potent anticonvulsant", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "favorable safety profile", "complex partial seizures", "typical maintenance dose", "VALPOTREAT CR 500 therapy", "VALPOTREAT CR 500 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1909, "imageuri": "https://productimages.withfloats.com/actual/666c100b8c6c791fd3b72fe4.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c100b8c6c791fd3b72fe4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:40:23.921Z", "updatedon": "2024-06-26T05:53:21.154Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-500-/1909", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 500 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 500 mg", "VALPOTREAT CR 500", "", "VALPOTREAT CR 500 price", "", "valprol cr 500 uses and side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67c98ea29006a7b5368cb903", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sucroferric Oxyhydroxide 2500 mg", "description": "RUDIX SUCRO FE contains Sucroferric Oxyhydroxide (2500 mg), a highly effective phosphate binder used in the management of chronic kidney disease (CKD) patients undergoing dialysis. It helps control high phosphate levels (hyperphosphatemia) in the blood, reducing the risk of bone disorders, cardiovascular complications, and other phosphate-related issues. Its iron-based composition ensures efficient phosphate binding while minimizing gastrointestinal side effects.\n\n \nKey Benefits:\n \n\n Effectively Lowers Phosphate Levels – Reduces phosphate absorption in CKD patients on dialysis.\n Prevents Bone & Heart Complications – Protects against renal osteodystrophy and vascular calcification.\n Iron-Based, Non-Calcium Formula – Minimizes the risk of hypercalcemia and calcium overload.\n Fast-Acting & Well-Tolerated – Begins working quickly and causes fewer gastrointestinal issues compared to other phosphate binders.\n Convenient Dosage & Administration – Requires fewer tablets per day, enhancing patient adherence.\n Supports Overall Kidney Health – Helps manage phosphorus balance, improving long-term health outcomes in CKD patients.\n\n \nHow Does It Work?\n \n\nSucroferric Oxyhydroxide acts as a phosphate binder, meaning it binds to dietary phosphate in the intestines and prevents its absorption into the bloodstream. Instead, the bound phosphate is excreted through the stool, effectively lowering serum phosphate levels. This helps protect the bones, heart, and blood vessels from damage caused by excess phosphorus accumulation.\n\n \nDirections for Use:\n \n\nTake as prescribed by a healthcare professional.\nThe usual recommended dose is 1 tablet with each meal, but the dose may be adjusted based on phosphate levels.\nSwallow the tablet whole or chew it before swallowing.\nAvoid taking it with other medications, as it may interfere with their absorption.\nRegular monitoring of phosphate levels is essential to adjust the dosage accordingly.\n \nSide Effects:\n \n\nWhile RUDIX SUCRO FE is generally well-tolerated, some possible side effects include:\n\nMild gastrointestinal issues (diarrhea, nausea, constipation)\nDark-colored stools due to iron content (this is harmless)\nMetallic taste or changes in taste perception\nRare allergic reactions (rash, itching, swelling)\nIf severe symptoms such as persistent stomach pain, vomiting, or difficulty breathing occur, seek immediate medical attention.", "price": 320.0, "discountamount": 96.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "1 tablet", "medical attention", "severe symptoms", "iron content", "generally welltolerated", "side effects", "adjusted based", "healthcare professional", "damage caused", "blood vessels", "bones heart", "helps protect", "renal osteodystrophy", "ckd patients", "phosphaterelated issues", "blood reducing", "bound phosphate", "dietary phosphate", "phosphate levels", "phosphate levels swallow", "absorption regular monitoring", "usual recommended dose", "phosphate binder meaning", "harmless metallic taste", "rudix sucro fe", "swallowing avoid taking" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2066, "imageuri": "https://productimages.withfloats.com/actual/67c98ec0bf545f60b10e551d.png", "tileimageuri": "https://productimages.withfloats.com/tile/67c98ec0bf545f60b10e551d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-06T12:01:38.223Z", "updatedon": "2025-03-06T12:02:07.953Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sucroferric-oxyhydroxide-2500-mg/2066", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RUDIX SUCRO FE", "category": "NEPHROLOGYRANGE", "tags": [ "Sucroferric oxyhydroxide tablet chewable 500 mg", "Sucroferric Oxyhydroxide chewable tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c0efb162db0236048ba8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 300 ", "description": "VALPOTREAT CR 300 \nSodium Valproate CR 300 mg\nIntroduction:\n\nVALPOTREAT CR 300 contains Sodium Valproate, a highly effective anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 300mg, VALPOTREAT CR 300 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 300 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 300 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 300 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 300 for adults typically starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 300 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 300 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-300-134219", "price": 78.0, "discountamount": 23.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "time", "food", "need", "EMAIL", "brain", "water", "adults", "option", "quality", "patients", "Benefits", "severity", "epilepsy", "adherence", "two doses", "frequency", "medication", "information", "mood swings", "Introduction", "initial dose", "sterisonline", "sterispharma", "tolerability", "GABA) levels", "Key Features", "various types", "CALL/WHATSAPP", "overall health", "Initial Dosage", "patient safety", "mood stability", "manic episodes", "steady release", "liver function", "mood stabilizer", "dosage strength", "symptom control", "frequent dosing", "bipolar disorder", "absence seizures", "seizure episodes", "neuronal activity", "treatment regimen", "clinical response", "Regular monitoring", "Mood Stabilization", "Sodium Valproate CR", "long-term management", "therapeutic efficacy", "Continued Monitoring", "Anticonvulsant Action", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "effective anticonvulsant", "complex partial seizures", "typical maintenance dose", "favorable safety profile", "VALPOTREAT CR 300 therapy", "VALPOTREAT CR 300 tablets", "Administration Instructions", "gastrointestinal discomfort", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1908, "imageuri": "https://productimages.withfloats.com/actual/666c0efef068be46bdec91c1.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c0efef068be46bdec91c1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:35:55.629Z", "updatedon": "2024-06-29T12:22:31.565Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//valpotreat-cr-300-/1908", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 300 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 300 mg", "VALPOTREAT CR 300", "", "VALPOTREAT CR 300", "valprol cr 300 side effects", "valprol cr 300 generic name", "valprol cr 300 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c0dc4a20cb421407442bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 200 ", "description": "VALPOTREAT CR 200 \nSodium Valproate CR 200 mg\nIntroduction:\n\nVALPOTREAT CR 200 contains Sodium Valproate, a widely used anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 200mg, VALPOTREAT CR 200 is designed to provide sustained therapeutic effects for the management of epilepsy and bipolar disorder, improving the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 200 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, which helps stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer in the treatment of bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 200 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This helps in achieving better symptom control and improving adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 200 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 200 for adults typically starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 200 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 200 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-200-134218", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "need", "life", "GABA", "food", "time", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "severity", "epilepsy", "Benefits", "patients", "adherence", "frequency", "two doses", "medication", "information", "mood swings", "Introduction", "initial dose", "Key Features", "tolerability", "sterispharma", "sterisonline", "CALL/WHATSAPP", "various types", "patient safety", "Initial Dosage", "overall health", "steady release", "liver function", "mood stability", "manic episodes", "dosage strength", "mood stabilizer", "symptom control", "frequent dosing", "absence seizures", "bipolar disorder", "seizure episodes", "clinical response", "treatment regimen", "neuronal activity", "Regular monitoring", "Mood Stabilization", "Sodium Valproate CR", "therapeutic efficacy", "long-term management", "Continued Monitoring", "Anticonvulsant Action", "usual maintenance dose", "consistent blood levels", "gamma-aminobutyric acid", "typical maintenance dose", "complex partial seizures", "favorable safety profile", "VALPOTREAT CR 200 therapy", "VALPOTREAT CR 200 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1907, "imageuri": "https://productimages.withfloats.com/actual/666c0dc8c9162f54a15a020e.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c0dc8c9162f54a15a020e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:30:44.587Z", "updatedon": "2024-06-26T09:16:37.475Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-200-/1907", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 200 ", "category": "NEUROLOGY RANGE", "tags": [ "VALPOTREAT CR 200", "Sodium Valproate CR 200 mg", "valpotreat cr 200 uses in hindi", "valprol cr 200 uses in hindi", "valpotreat cr 200 expiry date", "valpotreat" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666436778da3a81d5c6a38ba", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE 500 PR ", "description": "MESALMILE 500 PR \nMesalamine DR (500mg)\nMESALMILE 500 PR is a medication containing Mesalamine DR (500mg). Mesalamine, also known as 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. It belongs to the class of aminosalicylates, which work locally in the intestines to reduce inflammation and relieve symptoms associated with IBD.\n\nMesalamine DR (delayed-release) tablets are designed to release the medication gradually throughout the digestive tract, targeting the inflamed areas effectively. By reducing inflammation, Mesalamine helps alleviate symptoms like abdominal pain, diarrhea, rectal bleeding, and urgency.\n\nThis medication is often prescribed as a maintenance therapy to keep IBD in remission and prevent flare-ups. It is important to take Mesalamine DR as directed by your healthcare provider to achieve the best results.\n\nCommon side effects of Mesalamine may include nausea, diarrhea, abdominal pain, headache, and rash. Serious side effects such as allergic reactions or worsening of IBD symptoms should be reported to your doctor promptly.\n\nMESALMILE 500 PR with Mesalamine DR (500mg) is an effective treatment option for managing inflammatory bowel diseases, providing relief from symptoms and improving quality of life for patients with ulcerative colitis or Crohn's disease.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mesalmile-500-pr-133780\n\n\n\n\n\n\n", "price": 256.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ASA", "rash", "IBD.", "life", "Crohn", "500mg", "class", "ORDER", "Email", "doctor", "relief", "nausea", "urgency", "release", "quality", "tablets", "headache", "diarrhea", "WhatsApp", "patients", "remission", "flare-ups", "worsening", "intestines", "medication", "information", "IBD symptoms", "inflammation", "best results", "sterispharma", "sterisonline", "Mesalamine DR", "abdominal pain", "inflamed areas", "rectal bleeding", "digestive tract", "aminosalicylates", "MESALMILE 500 PR", "allergic reactions", "ulcerative colitis", "healthcare provider", "maintenance therapy", "Common side effects", "Serious side effects", "5-aminosalicylic acid", "effective treatment option", "inflammatory bowel diseases" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1577, "imageuri": "https://productimages.withfloats.com/actual/666436792907db1524df80ef.png", "tileimageuri": "https://productimages.withfloats.com/tile/666436792907db1524df80ef.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:46:15.185Z", "updatedon": "2024-06-29T04:45:51.422Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mesalmile-500-pr-/1577", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MESALMILE 500 PR ", "category": "GASTROLOGYRANGE", "tags": [ "MESALMILE 500 PR", "Mesalamine DR 500mg price", "Mesalamine DR 500mg", "Mesalamine dosage", "What is the maximum dosage of mesalamine", "mesalamine 1.2gm tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MYCOPLASM M 500", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-m-500-133669\n\n\n\n\n\n\n", "price": 789.0, "discountamount": 237.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2024-06-29T05:30:13Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycoplasm-m-500/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66617ed97de2b5203089cd4b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MENEROPEN 500 IV", "description": "MENEROPEN 500 IV\nMeropenem (500mg)\nMeropenem is an intravenous antibiotic medication used to treat severe bacterial infections. Each vial of Meneropen 500 IV contains 500mg of Meropenem, a potent broad-spectrum antibiotic effective against a wide range of bacteria. It belongs to the carbapenem class of antibiotics, known for their effectiveness against Gram-positive and Gram-negative bacteria.\n\nMeneropen 500 IV is commonly prescribed for infections such as pneumonia, urinary tract infections, intra-abdominal infections, and bacterial meningitis. It works by inhibiting the formation of bacterial cell walls, leading to bacterial cell death.\n\nDosage and administration of Meneropen 500 IV are typically determined by the severity of the infection, patient's age, and medical condition. It is administered intravenously by a healthcare professional in a hospital or clinical setting.\n\nCommon side effects of Meropenem may include nausea, diarrhea, headache, rash, and injection site reactions. Serious side effects such as allergic reactions or severe gastrointestinal disturbances are rare but possible.\n\nIt's important to complete the full course of Meneropen 500 IV as prescribed by your doctor, even if symptoms improve before the course is finished. Skipping doses or stopping early can lead to antibiotic resistance and treatment failure.\n\nMeneropen 500 IV is a prescription medication and should only be used under the guidance of a healthcare professional. Always inform your doctor about any other medications or health conditions you have before starting Meropenem therapy.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n\nhttps://www.sterisonline.com/product/meneropen-500-iv-133908\n\n\n\n\n\n\n\n", "price": 529.0, "discountamount": 159.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "vial", "rash", "Email", "doses", "500mg", "Dosage", "doctor", "nausea", "patient", "severity", "WhatsApp", "diarrhea", "headache", "symptoms", "guidance", "hospital", "pneumonia", "formation", "wide range", "full course", "antibiotics", "sterispharma", "sterisonline", "Gram-positive", "effectiveness", "administration", "carbapenem class", "Meneropen 500 IV", "clinical setting", "Meropenem therapy", "health conditions", "other medications", "treatment failure", "medical condition", "allergic reactions", "Common side effects", "bacterial meningitis", "bacterial cell death", "bacterial cell walls", "Serious side effects", "antibiotic resistance", "Gram-negative bacteria", "prescription medication", "healthcare professional", "urinary tract infections", "injection site reactions", "intra-abdominal infections", "severe bacterial infections", "potent broad-spectrum antibiotic", "intravenous antibiotic medication", "severe gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1437, "imageuri": "https://productimages.withfloats.com/actual/66617edb8e77bb2c715688fb.png", "tileimageuri": "https://productimages.withfloats.com/tile/66617edb8e77bb2c715688fb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:18:17.237Z", "updatedon": "2024-06-29T09:19:22.888Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/meneropen-500-iv/1437", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MENEROPEN 500 IV", "category": "GENERAL RANGE", "tags": [ "MENEROPEN 500 IV", "Meropenem (500mg)", "Meropenem 500 mg price", "Meropenem 500 mg Injection price", "Tab Meropenem 500 mg uses", "Tab meropenem 500 mg dose", "Meropenem 500 mg IV" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }